Create Alert
Sign Up
Sign In
Sign In
Sign Up
Contact Us
Careers
Terms and Conditions
Privacy
About Us
Home
Livefeed
Market Data
Companies
Filings
Ownership Search
Mutual Fund Search
Watchlist
My Watchlist
Create Alerts to view your Watchlist
Live Feed
Feed to the latest filings at the SEC
Type of Filers
All
Mutual Funds
Mutual 3 & ETFs
Mutual 2 & ETFs
Variable Insurance Products
Variable Insurance 1
Variable Insurance 3
Variable Insurance 4
Type of Forms
All
Annual Reports
10-K
10-K/A
18-K
20-F
20-F/A
24F-2NT
24F-2NT/A
40FR12B
MA/A
MA-I
MA-I/A
N-CSR
NSAR-B
NSAR-B/A
NT 10-K
TA-2/A
Quarterly Reports
10-Q
10-Q/A
N-Q
Proxy Statements
DEF 14 A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DFAN14A
N-PX/A
PRE 14 A
PRE 14C
PREC14A
PREM14A
PRER14A
PRRN14A
PX14A6G
Prospectus
425
POS AM
Current-Reports
8-K
8-K/A
Registrations
10-12B
10-12B/A
10-12G
10-12G/A
18-12B
18-12B/A
18-12G
18-12G/A
20FR12B
20FR12B/A
20FR12G
20FR12G/A
24F-2NT
24F-2NT/A
424A
424B1
424B2
424B3
424B4
424B5
424B7
485A24E
485BPOS
486BPOS
487
8-A12B
8-A12B/A
18-12G/A
8-A12G
8-A12G/A
DEL AM
F-1
F-1/A
F-1MEF
F-3
F-3/A
F-3DPOS
F-4
F-4/A
F-6
F-6/A
F-6 POS
N-1
N-14
N-14/A
N-1A
N-1/A
N-1A/A
N-2
N-2MEF
N-3
N-3/A
N-4
N-4/A
N-5
N-54A
N-54A/A
N-5/A
N-8A
N-8A/A
N-8B-2
N-8B-2/A
N-8B-4
N-8B-4/A
POS462B
POS462C
POS 8C
POS AM
POS AMI
POS EX
S-11
S-11/A
S-11MEF
S-1/A
S-1MEF
S-20
S-20/A
S-3
S-3/A
S-3D
S-3DPOS
S-3MEF
S-4EF
S-4MEF
S-4 POS
S-6
S-6/A
S-8
S-8 POS
Date Range
All
One Day Prior
Two Day Prior
Three Day Prior
LANTERN PHARMA INC.
Date Filed :
Apr 26, 2024
View Exhibits
Form 144 Filer Information
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144
144: Filer Information
Filer CIK
0001716869
Filer CCC
XXXXXXXX
Is this a LIVE or TEST Filing?
LIVE
TEST
Submission Contact Information
Name
Phone
E-Mail Address
144: Issuer Information
Name of Issuer
Lantern Pharma Inc.
SEC File Number
001-39318
Address of Issuer
1920 MCKINNEY AVENUE, 7TH FLOOR
DALLAS
TEXAS
75201
Phone
972-277-1136
Name of Person for Whose Account the Securities are To Be Sold
Bios Fund II QP, LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer
Affiliate (10% owner)
144: Securities Information
Title of the Class of Securities To Be Sold
Name and Address of the Broker
Number of Shares or Other Units To Be Sold
Aggregate Market Value
Number of Shares or Other Units Outstanding
Approximate Date of Sale
Name the Securities Exchange
Common Stock
Sanders Morris Harris
5950 Sherry Lane, Ste 470
Dallas � TX � 75225
407845
2177892.30
10741324
04/29/2024
NASDAQ
Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:
144: Securities To Be Sold
Title of the Class
Date you Acquired
Nature of Acquisition Transaction
Name of Person from Whom Acquired
Is this a Gift?
Date Donor Acquired
Amount of Securities Acquired
Date of Payment
Nature of Payment
*
Common Stock
06/15/2020
Conversion of Shares in IPO
Issuer
723610
06/15/2020
Conversion
*
If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
144: Securities Sold During The Past 3 Months
Name and Address of Seller
Title of Securities Sold
Date of Sale
Amount of Securities Sold
Gross Proceeds
Bios Fund II QP, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/27/2024
34731
152816.40
Bios Fund II QP, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/28/2024
51608
250298.80
Bios Fund II QP, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/29/2024
13686
66650.82
Bios Fund II NT, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/27/2024
4649
20455.60
Bios Fund II NT, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/28/2024
6909
33508.65
Bios Fund II NT, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/29/2024
1832
8921.84
Bios Fund II, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/27/2024
10620
46728.00
Bios Fund II, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/28/2024
15780
76533.00
Bios Fund II, LP
1751 River Run, Suite 400
Fort Worth � TX � 76107
Common Stock
02/29/2024
4185
20380.95
144: Remarks and Signature
Remarks
Date of Notice
04/26/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature
/s/ Daniel Schwarz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)
Stock View
Indices
by TradingView